Marks Group Wealth Management Inc Has $6.93 Million Holdings in STERIS plc (NYSE:STE)

Marks Group Wealth Management Inc decreased its position in shares of STERIS plc (NYSE:STE) by 1.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,710 shares of the medical equipment provider’s stock after selling 329 shares during the quarter. Marks Group Wealth Management Inc’s holdings in STERIS were worth $6,929,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of STE. Bleakley Financial Group LLC raised its stake in STERIS by 8.7% during the third quarter. Bleakley Financial Group LLC now owns 1,680 shares of the medical equipment provider’s stock worth $407,000 after buying an additional 134 shares during the last quarter. Franklin Resources Inc. grew its stake in STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after purchasing an additional 529,308 shares during the period. Assetmark Inc. lifted its stake in STERIS by 24.6% in the third quarter. Assetmark Inc. now owns 13,410 shares of the medical equipment provider’s stock valued at $3,252,000 after buying an additional 2,647 shares during the period. KBC Group NV lifted its position in shares of STERIS by 52.0% during the 3rd quarter. KBC Group NV now owns 12,071 shares of the medical equipment provider’s stock valued at $2,928,000 after acquiring an additional 4,132 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of STERIS by 30.8% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider’s stock worth $2,275,000 after purchasing an additional 2,583 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In other news, SVP Cary L. Majors sold 1,682 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $217.32, for a total value of $365,532.24. Following the completion of the transaction, the senior vice president now directly owns 11,372 shares of the company’s stock, valued at $2,471,363.04. This trade represents a 12.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on STE shares. StockNews.com cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, November 8th. JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler lifted their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, Stephens reissued an “overweight” rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Stock Down 0.4 %

STE stock opened at $223.52 on Wednesday. The stock has a market cap of $22.06 billion, a P/E ratio of 47.46 and a beta of 0.84. The company has a current ratio of 2.13, a quick ratio of 1.55 and a debt-to-equity ratio of 0.32. The stock’s fifty day simple moving average is $212.67 and its two-hundred day simple moving average is $224.43. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be issued a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.